Jing Deng
14Patents
2h-index
26Co-inventors
50Inventor score
Filing activity: Jul 27, 2011 → Oct 17, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10632209B2 | ASH1L inhibitors and methods of treatment therewith | Chemistry; Metallurgy | 7 | Active |
| US11147885B2 | ASH1L inhibitors and methods of treatment therewith | Chemistry; Metallurgy | 3 | Active |
| US11110177B2 | ASH1L degraders and methods of treatment therewith | Chemistry; Metallurgy | 2 | Active |
| US11786602B2 | ASH1L degraders and methods of treatment therewith | Chemistry; Metallurgy | 1 | Active |
| US9266911B2 | Camptothecin derivative, and preparation method thereof, and pharmaceutical composition and application | Chemistry; Metallurgy | 1 | Active |
| US12285490B2 | ASH1L degraders and methods of treatment therewith | Chemistry; Metallurgy | 0 | Active |
| US9902715B2 | Compounds | Chemistry; Metallurgy | 0 | Active |
| US12194024B2 | Pharmaceutical composition of MDM2 inhibitor and use thereof for preventing and/or treating disease | Chemistry; Metallurgy | 0 | Active |
| US9334299B2 | Water-soluble camptothecin derivative, pharmaceutical composition and use thereof | Chemistry; Metallurgy | 0 | Active |
| US11833210B2 | ASH1L inhibitors and methods of treatment therewith | Chemistry; Metallurgy | 0 | Active |
| US12083136B2 | Combination of BCL-2/BCL-XL inhibitors and chemotherapeutic agent and use thereof | Human Necessities | 0 | Active |
| US11633490B2 | ASH1L degraders and methods of treatment therewith | General | 0 | Revoked |
| US11883381B2 | ASH1L inhibitors and methods of treatment therewith | Chemistry; Metallurgy | 0 | Active |
| US9902735B2 | Heteroaryl substituted compounds as RORγ inhibitors | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.